Popular Categories
FDA Authorizes Expanded Use for REGEN-COV mAb
The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).
Aug 05, 2021 | Guest Author
Tools & Resources, ID Featured, Infection, Prevention, and Control, Infectious DiseaseNew Report: Local Health Department Infection Prevention and Control Training NeedsTo advance local health department engagement in IPC activities, NACCHO, in partnership with Project Firstline, released a new report highlighting the IPC activities conducted by LHDs, their training needs, and opportunities to bolster IPC capacity at the local level. Sep 08, 2021 | Erin Laird |
COVID-19FDA Authorizes Expanded Use for REGEN-COV mAbThe FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab). Aug 05, 2021 | Guest Author |
Subscribe Today
Sign Up for the E-mail Digests
Create an account or login to MyNACCHO and go to "My Subscriptions."
SUBSCRIBE NOWPARTNER ARTICLES
More NACCHO Blogs
Check out all the NACCHO blogs.